Piloting a Novel Approach for Collecting and Analyzing Travel History Data - Results and Next Steps
Over a 6-month period, an applied research team collected pilot data using this set of standardized travel history case investigation questions, as well as subjective feedback from investigators regarding baseline attitudes toward travel history questions and the efficiency and usefulness of these questions. Diseases for which the travel history questions were asked included seven zoonotic/vectorborne diseases (Lyme disease—erythema migrans cases only, anaplasmosis, ehrlichiosis, babesiosis, tickborne relapsing fever, tularemia, West Nile virus) and two primarily waterborne diseases (cryptosporidiosis, giardiasis).
Efforts are now beginning to examine all of the data and determine the most useful and appropriate analysis questions. During this roundtable we propose that we review the evaluation responses and data completion rates for each of the nine pilot diseases and discuss potential analysis implications and possible dissemination plans for results and recommendations. In addition, this roundtable will discuss potential next steps and recommendations for how to move forward with the findings from this pilot project. While the existing evaluation plan includes general analysis plans and direction, the novelty of the data and data collection process leans itself to an open and intriguing dialogue about the best uses of this type of data as well as potential challenges and pitfalls for the analysis and interpretation.
Discuss results and next steps for novel travel history case investigation questions.
Keyword(s): Epidemiology, Surveillance
Qualified on the content I am responsible for because: I am the Council of State and Territorial Epidemiologists staff lead on the Travel History Workgroup, which developed the piloted travel history case investigation questions. I have been a research analyst at CSTE for 2 years on surveillance/informatics and various infectious disease-related projects.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.